查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1697157

全球 IVD 试剂市场：产业分析、规模、份额、成长、趋势和预测（2025-2032 年）

IVD Reagents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 182 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计2025年全球IVD试剂市场规模将达到774亿美元，到2032年将达到1,195亿美元，预测期间（2025-2032年）的复合年增长率为6.4%。

体外诊断（IVD）试剂是诊断测试中使用的关键组件，有助于检测、监测和治疗各种疾病。这些试剂广泛应用于临床实验室、医院和研究机构，从传染病检查到肿瘤学和基因检测。对个人化医疗的关注度不断提高、慢性病盛行率不断上升以及对就地检验的需求不断增加是推动市场发展的关键因素。分子诊断和免疫测量等诊断技术的进步进一步推动了对体外诊断试剂的需求。

全球体外诊断（IVD）试剂市场受到多种因素的推动，包括感染疾病、癌症和糖尿病等慢性疾病以及对疾病早期检测的需求。次世代定序(NGS) 和聚合酵素链锁反应(PCR) 等先进诊断技术的采用正在加速对高品质试剂的需求。此外，医疗保健基础设施的扩张，尤其是在新兴国家，正在促进人们更多地获得诊断服务。政府推动疾病早期诊断的措施和不断上涨的医疗成本也促进了市场的成长。

儘管体外诊断市场预计将迎来良好的成长前景，但它仍面临着许多挑战，包括严格的监管要求以及与先进诊断测试相关的高成本。新型试剂监管核准的复杂性可能会延迟市场进入并影响创新解决方案的开发。此外，对测试结果的可重复性和准确性的担忧可能会阻碍市场采用。特别是在资源有限的环境中，专用试剂的高成本成为其广泛采用的障碍，限制了某些地区的市场扩张。

由于诊断技术的不断进步和医疗保健研究投资的增加，体外诊断试剂市场提供了巨大的成长机会。数位化和人工智慧主导的诊断技术的兴起有望提高检测的效率和准确性，为市场进入者开闢新的途径。此外，家用和自我检测套组的日益普及检测套组开启了新的收益来源。此外，与试剂製造商和医疗保健提供者合作开发适合新兴市场的经济高效的解决方案提供了有利可图的机会。伴同性诊断在精准医疗中的应用不断扩大也是一个关键的成长领域。

本报告研究了全球 IVD 试剂市场，并根据试剂类型、技术、应用、最终用途行业、区域趋势和公司概况进行了详细细分。

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
  • 宏观经济因素
  • COVID-19影响分析
  • 预测因子－相关性和影响力

第三章 增值洞察

第四章全球IVD试剂市场展望

  • 主要亮点
  • 市场规模分析及预测
    • 2019-2024 年历史市场规模分析
    • 2025-2032年目前市场规模分析与预测
  • 全球IVD试剂市场展望（按试剂类型）
    • 简介/主要发现
    • 2019 年至 2024 年试剂类型市场规模历史分析
    • 2025-2032 年试剂类型市场规模分析及预测
    • 按试剂类型分析市场吸引力
  • 全球IVD试剂市场技术展望
    • 简介/主要发现
    • 2019 年至 2024 年按技术分類的历史市场规模分析
    • 2025 年至 2032 年按技术分類的当前市场规模分析与预测
    • 依技术进行市场吸引力分析
  • 全球IVD试剂市场应用前景
    • 简介/主要发现
    • 2019 年至 2024 年按应用分類的历史市场规模分析
    • 2025 年至 2032 年按应用分類的当前市场规模分析与预测
    • 按应用进行市场吸引力分析
  • 全球IVD试剂市场前景（依最终用途产业）
    • 简介/主要发现
    • 2019 年至 2024 年按最终用途产业分類的历史市场规模分析
    • 2025 年至 2032 年终端用途产业市场规模分析及预测
    • 按最终用途行业进行的市场吸引力分析

5. 全球IVD试剂市场区域展望

  • 主要亮点
  • 2019 年至 2024 年各地区历史市场规模分析
  • 2025 年至 2032 年各地区目前市场规模分析与预测
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 按地区分析市场吸引力

6. 北美IVD试剂市场展望

7. 欧洲IVD试剂市场展望

第八章东亚IVD试剂市场展望

9. 南亚及大洋洲IVD试剂市场展望

第十章拉丁美洲IVD试剂市场展望

第11章中东和非洲IVD试剂市场展望

第十二章竞争格局

  • 2025年市场占有率分析
  • 市场结构
  • 公司简介（详情－概述、财务状况、策略、最新发展）
    • Abbott
    • Michelin
    • Agilent Technologies
    • Becton Dickinson
    • BioMerieux
    • Bio-Rad
    • Danaher
    • DiaSorin
    • Roche
    • Seegene
    • Sysmex
    • Thermo Fisher Scientific
    • Siemens Helthineers
    • Transasia Bio-Medicals Ltd.
    • Beacon Diagnostics Pvt. Ltd.
    • 其他的

第十三章 附录

简介目录
Product Code: PMRREP35181

Persistence Market Research has recently released a comprehensive report on the worldwide market for IVD Reagents. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global IVD Reagents market from 2025 to 2032.

Key Insights:

  • IVD Reagents Market Size (2025E): US$ 77.4 Bn
  • Market Value Forecast (2032F): US$ 119.5 Bn
  • Projected Growth (CAGR 2025 to 2032): 6.4%

IVD Reagents Market - Report Scope:

IVD (In Vitro Diagnostics) reagents are essential components used in diagnostic testing, facilitating the detection, monitoring, and treatment of various diseases. These reagents are widely used in clinical laboratories, hospitals, and research institutions for applications ranging from infectious disease testing to oncology and genetic testing. The growing emphasis on personalized medicine, increased prevalence of chronic diseases, and rising demand for point-of-care testing are key factors driving the market. Technological advancements in diagnostic techniques, such as molecular diagnostics and immunoassays, are further fueling the demand for IVD reagents.

Market Growth Drivers:

The global IVD reagents market is driven by several factors, including the rising burden of infectious diseases, chronic conditions such as cancer and diabetes, and the need for early disease detection. The adoption of advanced diagnostic technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR), is accelerating the demand for high-quality reagents. Additionally, the expansion of healthcare infrastructure, particularly in emerging economies, is facilitating greater access to diagnostic services. Government initiatives promoting early disease diagnosis and increased healthcare expenditure are also contributing to market growth.

Market Restraints:

Despite promising growth prospects, the IVD reagents market faces challenges such as stringent regulatory requirements and high costs associated with advanced diagnostic testing. The complexity of regulatory approvals for new reagents can delay market entry, impacting the development of innovative solutions. Additionally, concerns regarding the reproducibility and accuracy of test results may hinder market adoption. The high costs of specialized reagents, particularly in resource-limited settings, pose a barrier to widespread use, limiting market expansion in some regions.

Market Opportunities:

The IVD reagents market presents significant growth opportunities driven by ongoing advancements in diagnostic technologies and increasing investment in healthcare research. The rise of digital and AI-driven diagnostics is expected to enhance the efficiency and accuracy of testing, creating new avenues for market players. The growing trend of at-home and self-testing kits is also opening new revenue streams. Additionally, partnerships between reagent manufacturers and healthcare providers for the development of cost-effective solutions tailored to emerging markets offer lucrative opportunities. The increasing application of companion diagnostics in precision medicine is another key area of growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the IVD reagents market globally?
  • How do advancements in molecular diagnostics impact the demand for IVD reagents?
  • Which diagnostic segments are experiencing the highest growth within the market?
  • Who are the key players in the IVD reagents market, and what strategies are they employing to maintain competitiveness?
  • What are the emerging trends and future growth prospects in the global IVD reagents market?

Competitive Intelligence and Business Strategy:

Leading players in the global IVD reagents market, including Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Danaher Corporation, and Bio-Rad Laboratories, are focusing on research and development, strategic partnerships, and product innovation to strengthen their market position. Companies are investing in automation and digital healthcare solutions to enhance diagnostic capabilities. Collaborations with biotech firms and research institutions for the development of novel reagents are also a key strategy. The expansion of product portfolios through mergers and acquisitions is further shaping the competitive landscape of the market.

Key Companies Profiled:

  • Abbott
  • Agilent Technologies
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Danaher
  • DiaSorin
  • Roche
  • Seegene
  • Sysmex
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Transasia Bio-Medicals Ltd.
  • Beacon Diagnostics Pvt. Ltd.

IVD Reagents Market Segmentation

By Type of Reagent

  • Antibodies
  • Antigens
  • Oligonucleotides
  • Enzymes
  • Nucleic Acid Probes

By Technology

  • Immunoassay
  • Molecular Diagnostics
  • Clinical Chemistry
  • Hematology
  • Microbiology

By Application

  • Infectious Diseases
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Diseases
  • Genetic Testing
  • Neurology

By End-Use Industry

  • Hospitals
  • Clinical Laboratories
  • Point-of-Care Testing Facilities
  • Home Care Settings

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global IVD Reagents Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Application Epidemiology
  • 3.3. Pipeline Analysis
  • 3.4. Product Adoption Analysis
  • 3.5. Value Chain Analysis
  • 3.6. Key Promotional Strategies by Manufacturers
  • 3.7. PESTLE Analysis
  • 3.8. Porter's Five Force Analysis

4. Global IVD Reagents Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global IVD Reagents Market Outlook: Type of Reagent
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Type of Reagent, 2019-2024
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
      • 4.3.3.1. Antibodies
      • 4.3.3.2. Antigens
      • 4.3.3.3. Oligonucleotides
      • 4.3.3.4. Enzymes
      • 4.3.3.5. Nucleic Acid Probes
      • 4.3.3.6. Others
    • 4.3.4. Market Attractiveness Analysis: Type of Reagent
  • 4.4. Global IVD Reagents Market Outlook: Technology
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019-2024
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
      • 4.4.3.1. Immunoassay
      • 4.4.3.2. Molecular Diagnostics
      • 4.4.3.3. Clinical Chemistry
      • 4.4.3.4. Hematology
      • 4.4.3.5. Microbiology
      • 4.4.3.6. Others
    • 4.4.4. Market Attractiveness Analysis: Technology
  • 4.5. Global IVD Reagents Market Outlook: Application
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 4.5.3.1. Infectious Diseases
      • 4.5.3.2. Cancer/Oncology
      • 4.5.3.3. Cardiology
      • 4.5.3.4. Autoimmune Diseases
      • 4.5.3.5. Genetic Testing
      • 4.5.3.6. Neurology
      • 4.5.3.7. Others
    • 4.5.4. Market Attractiveness Analysis: Application
  • 4.6. Global IVD Reagents Market Outlook: End-Use Industry
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Bn) Analysis, By End-Use Industry, 2019-2024
    • 4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
      • 4.6.3.1. Hospitals
      • 4.6.3.2. Point-Of-Care Testing Facilities
      • 4.6.3.3. Home Care Settings
      • 4.6.3.4. Others
    • 4.6.4. Market Attractiveness Analysis: End-Use Industry

5. Global IVD Reagents Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America IVD Reagents Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Type of Reagent
    • 6.2.3. By Technology
    • 6.2.4. By Application
    • 6.2.5. By Application
    • 6.2.6. By End-Use Industry
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 6.4.1. Antibodies
    • 6.4.2. Antigens
    • 6.4.3. Oligonucleotides
    • 6.4.4. Enzymes
    • 6.4.5. Nucleic Acid Probes
    • 6.4.6. Others
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 6.5.1. Immunoassay
    • 6.5.2. Molecular Diagnostics
    • 6.5.3. Clinical Chemistry
    • 6.5.4. Hematology
    • 6.5.5. Microbiology
    • 6.5.6. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 6.6.1. Infectious Diseases
    • 6.6.2. Cancer/Oncology
    • 6.6.3. Cardiology
    • 6.6.4. Autoimmune Diseases
    • 6.6.5. Genetic Testing
    • 6.6.6. Neurology
    • 6.6.7. Others
  • 6.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 6.7.1. Hospitals
    • 6.7.2. Point-Of-Care Testing Facilities
    • 6.7.3. Home Care Settings
    • 6.7.4. Others
  • 6.8. Market Attractiveness Analysis

7. Europe IVD Reagents Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Type of Reagent
    • 7.2.3. By Technology
    • 7.2.4. By Application
    • 7.2.5. By Application
    • 7.2.6. By End-Use Industry
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 7.4.1. Antibodies
    • 7.4.2. Antigens
    • 7.4.3. Oligonucleotides
    • 7.4.4. Enzymes
    • 7.4.5. Nucleic Acid Probes
    • 7.4.6. Others
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 7.5.1. Immunoassay
    • 7.5.2. Molecular Diagnostics
    • 7.5.3. Clinical Chemistry
    • 7.5.4. Hematology
    • 7.5.5. Microbiology
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.6.1. Infectious Diseases
    • 7.6.2. Cancer/Oncology
    • 7.6.3. Cardiology
    • 7.6.4. Autoimmune Diseases
    • 7.6.5. Genetic Testing
    • 7.6.6. Neurology
    • 7.6.7. Others
  • 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 7.7.1. Hospitals
    • 7.7.2. Point-Of-Care Testing Facilities
    • 7.7.3. Home Care Settings
    • 7.7.4. Others
  • 7.8. Market Attractiveness Analysis

8. East Asia IVD Reagents Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Type of Reagent
    • 8.2.3. By Technology
    • 8.2.4. By Application
    • 8.2.5. By Application
    • 8.2.6. By End-Use Industry
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 8.4.1. Antibodies
    • 8.4.2. Antigens
    • 8.4.3. Oligonucleotides
    • 8.4.4. Enzymes
    • 8.4.5. Nucleic Acid Probes
    • 8.4.6. Others
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 8.5.1. Immunoassay
    • 8.5.2. Molecular Diagnostics
    • 8.5.3. Clinical Chemistry
    • 8.5.4. Hematology
    • 8.5.5. Microbiology
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.6.1. Infectious Diseases
    • 8.6.2. Cancer/Oncology
    • 8.6.3. Cardiology
    • 8.6.4. Autoimmune Diseases
    • 8.6.5. Genetic Testing
    • 8.6.6. Neurology
    • 8.6.7. Others
  • 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 8.7.1. Hospitals
    • 8.7.2. Point-Of-Care Testing Facilities
    • 8.7.3. Home Care Settings
    • 8.7.4. Others
  • 8.8. Market Attractiveness Analysis

9. South Asia & Oceania IVD Reagents Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Type of Reagent
    • 9.2.3. By Technology
    • 9.2.4. By Application
    • 9.2.5. By Application
    • 9.2.6. By End-Use Industry
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 9.4.1. Antibodies
    • 9.4.2. Antigens
    • 9.4.3. Oligonucleotides
    • 9.4.4. Enzymes
    • 9.4.5. Nucleic Acid Probes
    • 9.4.6. Others
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 9.5.1. Immunoassay
    • 9.5.2. Molecular Diagnostics
    • 9.5.3. Clinical Chemistry
    • 9.5.4. Hematology
    • 9.5.5. Microbiology
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.6.1. Infectious Diseases
    • 9.6.2. Cancer/Oncology
    • 9.6.3. Cardiology
    • 9.6.4. Autoimmune Diseases
    • 9.6.5. Genetic Testing
    • 9.6.6. Neurology
    • 9.6.7. Others
  • 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 9.7.1. Hospitals
    • 9.7.2. Point-Of-Care Testing Facilities
    • 9.7.3. Home Care Settings
    • 9.7.4. Others
  • 9.8. Market Attractiveness Analysis

10. Latin America IVD Reagents Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Type of Reagent
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By Application
    • 10.2.6. By End-Use Industry
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 10.4.1. Antibodies
    • 10.4.2. Antigens
    • 10.4.3. Oligonucleotides
    • 10.4.4. Enzymes
    • 10.4.5. Nucleic Acid Probes
    • 10.4.6. Others
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 10.5.1. Immunoassay
    • 10.5.2. Molecular Diagnostics
    • 10.5.3. Clinical Chemistry
    • 10.5.4. Hematology
    • 10.5.5. Microbiology
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.6.1. Infectious Diseases
    • 10.6.2. Cancer/Oncology
    • 10.6.3. Cardiology
    • 10.6.4. Autoimmune Diseases
    • 10.6.5. Genetic Testing
    • 10.6.6. Neurology
    • 10.6.7. Others
  • 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 10.7.1. Hospitals
    • 10.7.2. Point-Of-Care Testing Facilities
    • 10.7.3. Home Care Settings
    • 10.7.4. Others
  • 10.8. Market Attractiveness Analysis

11. Middle East & Africa IVD Reagents Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Type of Reagent
    • 11.2.3. By Technology
    • 11.2.4. By Application
    • 11.2.5. By Application
    • 11.2.6. By End-Use Industry
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 11.4.1. Antibodies
    • 11.4.2. Antigens
    • 11.4.3. Oligonucleotides
    • 11.4.4. Enzymes
    • 11.4.5. Nucleic Acid Probes
    • 11.4.6. Others
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 11.5.1. Immunoassay
    • 11.5.2. Molecular Diagnostics
    • 11.5.3. Clinical Chemistry
    • 11.5.4. Hematology
    • 11.5.5. Microbiology
    • 11.5.6. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.6.1. Infectious Diseases
    • 11.6.2. Cancer/Oncology
    • 11.6.3. Cardiology
    • 11.6.4. Autoimmune Diseases
    • 11.6.5. Genetic Testing
    • 11.6.6. Neurology
    • 11.6.7. Others
  • 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 11.7.1. Hospitals
    • 11.7.2. Point-Of-Care Testing Facilities
    • 11.7.3. Home Care Settings
    • 11.7.4. Others
  • 11.8. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Abbott
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Michelin
    • 12.3.3. Agilent Technologies
    • 12.3.4. Becton Dickinson
    • 12.3.5. BioMerieux
    • 12.3.6. Bio-Rad
    • 12.3.7. Danaher
    • 12.3.8. DiaSorin
    • 12.3.9. Roche
    • 12.3.10. Seegene
    • 12.3.11. Sysmex
    • 12.3.12. Thermo Fisher Scientific
    • 12.3.13. Siemens Helthineers
    • 12.3.14. Transasia Bio-Medicals Ltd.
    • 12.3.15. Beacon Diagnostics Pvt. Ltd.
    • 12.3.16. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations